However, there are no inducible and defined niche-specific genetically engineered human cancer organoids described in the literature to our knowledge, We have taken the approach of creating a doxycycline-inducible triple-targeting (TP53-PTEN-NF1) shRNA method and compared it to un-induced human cerebral organoids. The gene discussed is TP53; the disease is cancer.